Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C

被引：32

作者：

Annicchiarico, BE ^{[1
]}

Siciliano, M ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Fac Med & Chirurg, Ist Patol Speciale Med & Semeiot Med, Rome, Italy

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2004年 / 20卷 / 01期

关键词：

D O I：

10.1111/j.1365-2036.2004.01954.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：123 / 124

页数：2

共 5 条

[1] Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C [J].

Bruchfeld, A ;

Ståhle, L ;

Andersson, J ;

Schvarcz, R .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (08) :1729-1729

[2] Hepatitis C infection and the patient with end-stage renal disease [J].

Fabrizi, F ;

Poordad, FF ;

Martin, P .

HEPATOLOGY, 2002, 36 (01) :3-10

[3] Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients [J].

Fabrizi, F ;

Dulai, G ;

Dixit, V ;

Bunnapradist, S ;

Martin, P .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) :1071-1081

[4] Understudied Populations with hepatitis C [J].

Strader, DB .

HEPATOLOGY, 2002, 36 (05) :S226-S236

[5] Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study [J].

Tan, ACITL ;

Brouwer, JT ;

Glue, P ;

van Leusen, R ;

Kauffmann, RH ;

Schalm, SW ;

de Vries, RA ;

Vroom, B .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (01) :193-195

← 1 →